June 22, 2026 · Form 4 insider transaction
HENDERSON MICHAEL THOMAS sold 20,000 shares of Spyre Therapeutics, Inc. at $100.00 per share, a transaction worth $2.00M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 6, 2026.